Your browser doesn't support javascript.
loading
The 2023 Practitioner's Toolkit for Managing Menopause.
Davis, S R; Taylor, S; Hemachandra, C; Magraith, K; Ebeling, P R; Jane, F; Islam, R M.
Afiliação
  • Davis SR; Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Taylor S; Department of Endocrinology and Diabetes, Alfred Health, Melbourne, VIC, Australia.
  • Hemachandra C; Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Magraith K; Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Ebeling PR; Ministry of Health, Colombo, Sri Lanka.
  • Jane F; Cascade Road General Practice, TAS, Australia.
  • Islam RM; College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia.
Climacteric ; 26(6): 517-536, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37902335
ABSTRACT

OBJECTIVE:

The Practitioner's Toolkit for Managing the Menopause, developed in 2014, provided an accessible desk-top tool for health-care practitioners caring for women at midlife. To ensure the Toolkit algorithms and supporting information reflect current best practice, the Toolkit has been revised in accordance with the published literature.

METHODS:

A systematic search for guidelines, position and consensus statements pertaining to the menopause and published after 2014 was undertaken, and key recommendations extracted from the Clinical Practice Guidelines determined to be the most robust by formal evaluation. The peer-reviewed literature was further searched for identified information gaps.

RESULTS:

The revised Toolkit provides algorithms that guide the clinical assessment and care of women relevant to menopause. Included are the reasons why women present, information that should be ascertained, issues that may influence shared decision-making and algorithms that assist with determination of menopausal status, menopause hormone therapy (MHT) and non-hormonal treatment options for symptom relief. As clear guidelines regarding when MHT might be indicated to prevent bone loss and subsequent osteoporosis in asymptomatic women were found to be lacking, the Toolkit has been expanded to support shared decision-making regarding bone health.

CONCLUSIONS:

The 2023 Toolkit and supporting document provide accessible desk-top information to support health-care providers caring for women at midlife.The Toolkit has been endorsed by the International Menopause Society, Australasian Menopause Society, British Menopause Society, Endocrine Society of Australia and Jean hailes for Women's Health.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Terapia de Reposição de Estrogênios Limite: Female / Humans Idioma: En Revista: Climacteric Assunto da revista: GINECOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Terapia de Reposição de Estrogênios Limite: Female / Humans Idioma: En Revista: Climacteric Assunto da revista: GINECOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
...